Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCros, Jerome
dc.contributor.authorCasanovas, Oriol
dc.contributor.authorCastaño, Justo P.
dc.contributor.authorDayton, Talya
dc.contributor.authorGIBERT, Benjamin
dc.contributor.authorGarcia-Alvarez, Alejandro
dc.date.accessioned2025-10-29T08:00:30Z
dc.date.available2025-10-29T08:00:30Z
dc.date.issued2025-10
dc.identifier.citationCros J, Casanovas O, Castaño JP, Dayton T, Alvarez AG, Gibert B, et al. White paper on best practices for translational research in neuroendocrine neoplasms. J Neuroendocrinol. 2025 Oct;37(10):e70072.
dc.identifier.issn1365-2826
dc.identifier.urihttp://hdl.handle.net/11351/13944
dc.descriptionCarcinoids; Genomics; Liquid biopsy
dc.description.abstractBasic and translational investigations play a crucial role in advancing our understanding of neuroendocrine neoplasms (NENs). In this white paper by the Basic and Translational Research Group of the European Neuroendocrine Tumor Society, we discuss the qualities and drawbacks of current disease models and propose good practices for integrating state-of-the-art technologies including bulk and single-cell genomics, transcriptomics, and proteomics in contemporary NEN research. We also provide insights on how to properly handle tissue samples (particularly when starting material is limited) and discuss technical hints of relevance when planning liquid biopsy or tumor immunology studies. Future translational studies of NENs will benefit from centralized biologic material biobanking, research design planning in the context of multi-expertise committees, as well as experimental protocol optimization and sharing across the NEN scientific community.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesJournal of Neuroendocrinology;37(10)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectTumors neuroendocrins
dc.subjectProteòmica
dc.subjectMedicina - Investigació
dc.subject.meshTranslational Medical Research
dc.subject.meshProteomics
dc.subject.meshNeuroendocrine Tumors
dc.titleWhite paper on best practices for translational research in neuroendocrine neoplasms
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1111/jne.70072
dc.subject.decsinvestigación médica traslacional
dc.subject.decsproteómica
dc.subject.decstumores neuroendocrinos
dc.relation.publishversionhttps://doi.org/10.1111/jne.70072
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Cros J] Department of Pathology, Beaujon Hospital (AP-HP), Université Paris Cité, Paris, France. [Casanovas O] ProCURE, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. [Castaño JP] Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain. Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Córdoba, Spain. Reina Sofia University Hospital, Córdoba, Spain. CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain. [Dayton T] Tissue Biology and Disease Modelling, European Molecular Biology Laboratory (EMBL) Barcelona, Barcelona, Spain. [Garcia Alvarez A] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gibert B] Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France
dc.identifier.pmid40717619
dc.identifier.wos001538248900001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record